Clinical TrialID 2840

Malic Acid in Treatment of Xerostomia

NCT04756986

Xerostomia

Back to Browse

Relationship Network

Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.

Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...

Record Fields

Scalar fields from the final clinical_trial record.

Clinical Trial Id
2840
Evidence Id
2840
Core Evidence Id
2840
Source Clinical Trial Id
2812
Herb2 Clinical Trial Id
HBCT002812
Nct Id
NCT04756986
Title
Malic Acid in Treatment of Xerostomia
Status
Phase
Study Result
No
Study Condition
Xerostomia
Study Type
Interventional
Study Design
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Intervention
DRUG: malic acid
Intervention Allocation
Randomized
Intervention Model
Parallel
Intervention Mask
Intervention Purpose
Treatment
Gender
All
Age
Adult
Enrollment
52
Outcome Measure
The unstimulated salivary flow rate, The unstimulated salivary flow rate will be obtained by the spit method every 30s for 15 minutes. Saliva will be collected in graduated tubes. Measurements will be expressed as milliliter per minute. Participants will be asked to refrain from eating, drinking and brushing their teeth at least 2 hours before saliva collection - Hypo-salivation if the unstimulated salivary flow rate 0.1- 0.2 ml/min or less, 4 weeks
Sponsor Collaborator
Hams Hamed Abdelrahman
Funded By
OTHER
Location
Faculty of Dentistry, Alexandria University, Alexandria, Egypt
Other Id
Malic acid in xerostomia
Start Date
2021-01-01
Primary Completion Date
2021-09-01
Completion Date
2021-11-01
First Posted
2021-02-16
Results First Posted
Last Update Posted
2021-02-16
Study Document
Study Url
https://clinicaltrials.gov/study/NCT04756986
Title Cn
Title En
Malic Acid in Treatment of Xerostomia
Bilingual Status
semi_complete